| Business Summary | | Fresenius
Medical
Care
AG,
is
a
kidney
dialysis
company
engaged
in
both
providing
dialysis
care
and
manufacturing
dialysis
products.
The
Company
provides
dialysis
treatment
to
over
91,900
patients
at
its
1,270
clinics,
920
of
which
are
in
the
United
States
and
350
of
which
are
in
17
countries
outside
of
the
United
States.
In
the
United
States,
the
Company
also
provides
inpatient
dialysis
services,
therapeutic
apheresis,
hemoperfusion
and
other
services
under
contract
to
hospitals.
The
Company
develops
and
manufactures
a
complete
range
of
equipment,
systems
and
disposable
products
that
it
sells
to
customers
in
over
100
countries.
Fresenius
Medical
Care
Holdings,
which
conducts
business
under
the
trade
name,
Fresenius
Medical
Care
North
America,
is
the
holding
company
for
all
of
the
Company's
operations
in
the
United
States
and
Canada
and
manufacturing
operations
in
Mexico. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Fresenius
Medical
Care
is
an
integrated
provider
of
dialysis
products
and
services.
FMS
provides
hemodialysis
and
peritoneal
dialysis
products,
supplies
and
services
for
the
treatment
of
renal
disease
in
over
100
countries.
For
the
six
months
ended
6/30/01,
total
revenues
rose
16%
to
$2.36
billion.
Net
income
applicable
to
Common
rose
22%
to
$115.4
million.
Results
reflect
an
increased
number
of
Dialysis
Care
treatments,
and
reduced
net
interest
expense. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Ben Lipps, 60 | Chairman
of the Management Board, CEO | Roberto Fuste, 48 | CEO
for Asia Pacific | Emanuele Gatti, 45 | CEO
for Europe, Middle East, Africa and Latin America |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|